NovaSom Announces New CEO John Spitznagel

  NovaSom Announces New CEO John Spitznagel

   Experienced executive to lead aggressive commercialization and growth of
                 in-home testing for Obstructive Sleep Apnea

Business Wire

GLEN BURNIE, Md. -- July 16, 2013

NovaSom, Inc., a leader in home sleep testing solutions for Obstructive Sleep
Apnea (OSA), appointed John Spitznagel as the Company’s new CEO, effective
immediately, as well as a member of the Board of Directors. Mr. Spitznagel
brings more than 45 years of experience as a successful healthcare executive,
with extensive knowledge of commercialization and growth strategies. Mr.
Spitznagel will succeed Richard Hassett, M.D., who has served as President and
CEO since 2010, and was responsible for overseeing the launch of AccuSom^®,
the first FDA-cleared wireless home sleep test, in 2011.

“NovaSom offers the best home sleep test available in the market today,” said
Jim Datin, NovaSom Board Member. “We are excited that John is joining the
NovaSom team. His experience in building successful commercialization programs
is exactly what we need at this time for the future success of the NovaSom’s
AccuSom Home Sleep Test. John will help make this test available to the
millions of consumers who need to be tested—and treated—for OSA.”

Mr. Spitznagel has a long track record of success in the healthcare industry.
Prior to joining NovaSom, Mr. Spitznagel served as Chairman and CEO of Oceana
Therapeutics, Inc., a medical device company focused on pediatric urology and
colon and rectal surgery. Under Spitznagel’s guidance, the Company grew sales
of its marketed product for vesicoureteral reflux and completed the clinical
development program and PMA submission for Solesta, its fecal incontinence
product. In December of 2011, Oceana was purchased by Salix Pharmaceuticals.
Prior to Oceana, Mr. Spitznagel served as Chairman and CEO for Esprit Pharma,
Inc., a specialty pharmaceutical company focused on the genito-urinary market.
He oversaw Esprit’s growth from a start-up in 2005 to its purchase by
Allergan, Inc. in 2007.Prior to that, Mr. Spitznagel was Chairman & CEO of
ESP Pharma, a company he co-founded to pursue the acquisition, development and
marketing of acute-care pharmaceuticals. Mr. Spitznagel led ESP’s rapid growth
in sales and profitability, leading to ESP’s acquisition. Before ESP, Mr.
Spitznagel was President & CEO of Roberts Pharmaceutical, which specialized in
acquiring in-market and late-stage development drugs. He joined Roberts in
1996 and led the Company through a dramatic turnaround in profitability and
the successful merger into Shire plc. Mr. Spitznagel also served as President
of the Reed and Carnrick division of Block Drug from. He began his career at
Warner-Lambert in sales and marketing and spent nearly ten years at
Hoffmann-La Roche and ten years at American Home Products where he was Senior
Vice President of Marketing and Sales for Wyeth.

“NovaSom is uniquely positioned in the market to meet the changing needs of
patients, physicians and sleep centers,” said Spitznagel. “We have a terrific
solution for in-home testing of OSA and the ability to help millions of people
live a healthier life. Once it is recognized how easy and convenient testing
can be, we are confident that AccuSom will quickly become the in-home test of
choice.”

About NovaSom, Inc.

NovaSom, Inc. is a market leader in Obstructive Sleep Apnea (OSA) home
testing, with the AccuSom^® Home Sleep Test, the first and only FDA-cleared
wireless HST. The NovaSom home sleep testing technology and MediTrack^® portal
have been shown to provide in-home, clinically equivalent diagnosis of OSA at
a significantly reduced cost as compared to in-facility testing for
uncomplicated, adult OSA. NovaSom's home sleep tests are currently covered for
more than 150 million commercially insured U.S. lives.

NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep
Diagnostic Center & Telehealth Provider and is classified by CMS as an
Independent Diagnostic Testing Facility. For more information, visit
www.NovaSom.com.

Contact:

Zer0 to 5ive
Alyson Kuritz, 908-892-7149